Viewing Study NCT00424333



Ignite Creation Date: 2024-05-05 @ 5:18 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00424333
Status: COMPLETED
Last Update Posted: 2007-02-13
First Post: 2007-01-17

Brief Title: Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes
Sponsor: Pfizer
Organization: Pfizer

Study Overview

Official Title: Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin in an Intensive Insulin Regimen for Subjects With Type 1 Diabetes Mellitus A Six-Month Outpatient Parallel Comparative Trial
Status: COMPLETED
Status Verified Date: 2007-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To determine in subjects with Type 1 Diabetes Mellitus

1 Whether glycemic control can be achieved at least as effectively with a an intensive insulin regimen involving pre-meal inhaled insulin plus twice daily subcutaneous NPH insulin as with b an intensive subcutaneous insulin regimen involving pre-meal regular insulin plus twice daily NPH given as 4 injections per day The treatment regimens differ only by the route of delivery of the short acting insulin
2 The toleration and safety of inhaled insulin therapy and its effects after 6months if any on measures of pulmonary function
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None